Navigation Links
'Swine Flu' Shot May Be Cleared of Guillain-Barre Charges
Date:7/13/2011

WEDNESDAY, July 13 (HealthDay News) -- A new European study finds that the supercharged vaccines used to fight the H1N1 epidemic in 2009 may not have boosted the risk for a disease known as Guillain-Barre syndrome after all.

Guillain-Barre is a rare disorder, which causes a person's immune system to damage nerve cells, resulting in muscle weakness and even paralysis.

In 1976, a vaccine used during a U.S. flu outbreak was linked to the disease, and the government halted vaccination. Debate has continued since then over whether vaccines in use could trigger the syndrome.

In a study published July 13 in the journal BMJ, a consortium of researchers reported that the H1N1 vaccine posed little, if any, increased risk for the disease.

"This study provides reassurance that adjuvanted pandemic influenza A (H1N1) 2009 vaccines did not increase the risk of Guillain-Barre syndrome substantially, if at all," they wrote in a journal news release.

Their conclusion stemmed from an analysis of 50 million people in five European countries that vaccinated people against H1N1 in 2009. The researchers compared 104 people with Guillain-Barre syndrome or a related condition to other people without the diseases.

The researchers adjusted their statistics to account for other risk factors for the diseases and found no link between flu vaccination and Guillain-Barre syndrome. Still, noting that it's possible a small risk might remain, they estimated there may be less than three extra cases of Guillain-Barre syndrome for each one million people who get protected by a flu vaccination.

Larger studies already in progress should provide even more definitive information, the study authors added.

More information

For more about flu vaccination, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCE: BMJ, news release, July 12, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Swine flu spread was much wider than first thought, scientists say
2. Tracking Swine Flu Virus in Pigs Reveals Mutations
3. A Year After Its Emergence, H1N1 Swine Flu Lingers
4. Officials See Uptick in H1N1 Swine Flu Cases
5. Swine Flu vaccination: voluntary system works
6. 96 percent of vasectomy patients cleared without need for multiple semen samples
7. Guillain-Barre Syndrome Very Rare After H1N1 Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Swine Flu' Shot May Be Cleared of Guillain-Barre Charges
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... a Property owned by an affiliate of Seavest, has won a prestigious national ... Southern Chester County ambulatory care center (ACC) was named “Best New Development, MOBs ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental Laboratories ... and patients about the safety issues related to dental restorations. According to the American ... projected to reach $6.4 billion in 2018 with more than 30 million Americans missing ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: